Suppr超能文献

利用CLIP评分预测肝细胞癌患者切除术后的复发及预后

Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.

作者信息

Zhao Wen-He, Ma Zhi-Min, Zhou Xing-Ren, Feng Yi-Zheng, Fang Bao-Shan

机构信息

Department of Oncosurgery, the First Affiliated Hospital, Zhejiang University, Medical College, 79 Qingchun, Hangzhou 310003, Zhejiang Province, China.

出版信息

World J Gastroenterol. 2002 Apr;8(2):237-42. doi: 10.3748/wjg.v8.i2.237.

Abstract

AIM

The survival time of patients with hepatocellular carcinoma (HCC) after resection is hard to predict. Both residual liver function and tumor extension factors should be considered. A new scoring system has recently been proposed by the Cancer of the Liver Italian Program (CLIP). CLIP score was confirmed to be one of the best ways to stage patients with HCC. To our knowledge, however, the literature concerning the correlation between CLIP score and prognosis for patients with HCC after resection was not published. The aim of this study is to evaluate the recurrence and prognostic value of CLIP score for the patients with HCC after resection.

METHODS

A retrospective survey was carried out in 174 patients undergoing resection of HCC from January 1986 to June 1998. Six patients who died in the hospital after operation and 11 patients with the recurrence of the disease were excluded at 1 month after hepatectomy. By the end of June 2001, 4 patients were lost and 153 patients with curative resection have been followed up for at least three years. Among 153 patients, 115 developed intrahepatic recurrence and 10 developed extrahepatic recurrence, whereas the other 28 remained free of recurrence. Recurrences were classified into early (< or =3 year) and late (>3 year) recurrence. The CLIP score included the parameters involved in the Child-Pugh stage (0-2), plus macroscopic tumor morphology (0-2), AFP levels (0-1), and the presence or absence of portal thrombosis (0-1). By contrast, portal vein thrombosis was defined as the presence of tumor emboli within vascular channel analyzed by microscopic examination in this study. Risk factors for recurrence and prognostic factors for survival in each group were analyzed by the chi-square test, the Kaplan-Meier estimation and the COX proportional hazards model respectively.

RESULTS

The 1-, 3-, 5-, 7-,and 10-year disease-free survival rates after curative resection of HCC were 57.2%, 28.3%, 23.5%, 18.8%, and 17.8%, respectively. Median survival time was 28, 10, 4, and 5 mo for CLIP score 0, 1, 2, 3, and 4 to 5, respectively. Early and late recurrence developed in 109 patients and 16 patients respectively. By the chi-square test, tumor size, microsatellite, venous invasion, tumor type (uninodular, multinodular, massive), tumor extension (< or = or >50% of liver parenchyma replaced by tumor), TNM stage, CLIP score, and resection margin were the risk factors for early recurrence, whereas CLIP score and Child-Pugh stage were significant risk factors for late recurrence. In univariate survival analysis, Child-Pugh stages, resection margin, tumor size, microsatellite, venous invasion, tumor type, tumor extension, TNM stages, and CLIP score were associated with prognosis. The multivariate analysis by COX proportional hazards model showed that the independent predictive factors of survival were resection margins and TNM stages.

CONCLUSION

CLIP score has displayed a unique superiority in predicting the tumor early and late recurrence and prognosis in the patients with HCC after resection.

摘要

目的

肝细胞癌(HCC)患者切除术后的生存时间难以预测。残余肝功能和肿瘤扩展因素均应予以考虑。意大利肝癌研究组(CLIP)最近提出了一种新的评分系统。CLIP评分已被证实是对HCC患者进行分期的最佳方法之一。然而,据我们所知,关于CLIP评分与HCC切除术后患者预后相关性的文献尚未发表。本研究的目的是评估CLIP评分对HCC切除术后患者的复发及预后价值。

方法

对1986年1月至1998年6月期间接受HCC切除术的174例患者进行回顾性调查。6例术后死于医院的患者以及11例术后1个月疾病复发的患者被排除。至2001年6月底,4例失访,153例根治性切除患者至少随访了3年。153例患者中,115例发生肝内复发,10例发生肝外复发,其余28例无复发。复发分为早期(≤3年)和晚期(>3年)复发。CLIP评分包括Child-Pugh分期(0 - 2)所涉及的参数,加上宏观肿瘤形态(0 - 2)、甲胎蛋白水平(0 - 1)以及门静脉血栓形成情况(0 - 1)。相比之下,本研究中门静脉血栓形成定义为通过显微镜检查在血管通道内存在肿瘤栓子。分别采用卡方检验、Kaplan-Meier估计法和COX比例风险模型分析每组患者复发的危险因素及生存的预后因素。

结果

HCC根治性切除术后1年、3年、5年、7年和10年的无病生存率分别为57.2%、28.3%、23.5%、18.8%和17.8%。CLIP评分为0、1、2、3以及4至5时,中位生存时间分别为28个月、10个月、4个月和5个月。早期和晚期复发分别发生在109例和16例患者中。通过卡方检验,肿瘤大小、微小卫星灶、静脉侵犯、肿瘤类型(单结节、多结节、巨块型)、肿瘤扩展(≤或>肝实质的50%被肿瘤取代)、TNM分期、CLIP评分和手术切缘是早期复发的危险因素,而CLIP评分和Child-Pugh分期是晚期复发的显著危险因素。在单因素生存分析中,Child-Pugh分期、手术切缘、肿瘤大小、微小卫星灶、静脉侵犯、肿瘤类型、肿瘤扩展、TNM分期和CLIP评分与预后相关。COX比例风险模型的多因素分析显示,生存的独立预测因素是手术切缘和TNM分期。

结论

CLIP评分在预测HCC切除术后患者肿瘤的早期和晚期复发及预后方面显示出独特的优势。

相似文献

5
[A new prognostic score system of hepatocellular carcinoma following hepatectomy].[一种肝切除术后肝细胞癌的新预后评分系统]
Zhonghua Zhong Liu Za Zhi. 2017 Dec 23;39(12):903-909. doi: 10.3760/cma.j.issn.0253-3766.2017.12.005.

引用本文的文献

本文引用的文献

1
Liver resection for cancer.肝癌肝切除术
World J Gastroenterol. 2001 Dec;7(6):766-71. doi: 10.3748/wjg.v7.i6.766.
2
Hepatocellular carcinoma--cause, treatment and metastasis.肝细胞癌——病因、治疗与转移
World J Gastroenterol. 2001 Aug;7(4):445-54. doi: 10.3748/wjg.v7.i4.445.
4
Progress in research of liver surgery in China.中国肝脏外科研究进展。
World J Gastroenterol. 2000 Dec;6(6):773-776. doi: 10.3748/wjg.v6.i6.773.
10
Clinical research advances in primary liver cancer.原发性肝癌的临床研究进展
World J Gastroenterol. 1998 Dec;4(6):471-474. doi: 10.3748/wjg.v4.i6.471.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验